Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Shanghai Pharmaceuticals Holding Co., Ltd    601607   CNE000000C82

SHANGHAI PHARMACEUTICALS HOLDING CO., LT

(601607)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
06/24/2020 06/29/2020 06/30/2020 07/01/2020 07/02/2020 Date
18.49 18.35 18.38 18.56 18.82 Last
15417080 17828560 16670060 21479500 25626660 Volume
+0.98% -0.76% +0.16% +0.98% +1.40% Change
Financials
Sales 2020 202 B 28 585 M 28 585 M
Net income 2020 4 641 M 657 M 657 M
Net Debt 2020 16 064 M 2 275 M 2 275 M
P/E ratio 2020 11,5x
Yield 2020 2,64%
Sales 2021 232 B 32 833 M 32 833 M
Net income 2021 5 103 M 723 M 723 M
Net Debt 2021 19 118 M 2 707 M 2 707 M
P/E ratio 2021 10,5x
Yield 2021 3,22%
Capitalization 47 368 M 6 704 M 6 707 M
EV / Sales 2020 0,31x
EV / Sales 2021 0,29x
Nbr of Employees 47 778
Free-Float 62,3%
More Financials
Company
Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The Company's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its products are applied in cardiovascular system, anti-cancer and immunoregulation, anti-infection and metabolism, as well as... 
More about the company
Surperformance© ratings of Shanghai Pharmaceuticals H
Trading Rating : Investor Rating :
More Ratings
Latest news on SHANGHAI PHARMACEUTICALS H
01/22ENZYMATICA PUBL : signs agreement with Keyuan Trade for China
AQ
2019SHANGHAI PHARMACEUTICALS : Grant of share options under the share option scheme
PU
2019SHANGHAI PHARMACEUTICALS : Results of the extraordinary general meeting, a share..
PU
2019SHANGHAI PHARMACEUTICALS : Notification Letter and Change Request Form to Regist..
PU
2019SHANGHAI PHARMACEUTICALS : Reply slip for holders of h share attending the 2019 ..
PU
2019SHANGHAI PHARMACEUTICALS : Form of proxy of holders of h shares for use at the 2..
PU
2019SHANGHAI PHARMACEUTICALS : Proxy form of the independent non-executive director ..
PU
2019SHANGHAI PHARMACEUTICALS : Notice of 2019 second h share class meeting
PU
2019SHANGHAI PHARMACEUTICALS : Reply slip for holders of h share attending the 2019 ..
PU
2019SHANGHAI PHARMACEUTICALS : Proxy form of holders of h shares for use at the 2019..
PU
2019SHANGHAI PHARMACEUTICALS : Proxy form of the independent non-executive director ..
PU
2019SHANGHAI PHARMACEUTICALS : Proposed Adoption of the 2019 Share Option Scheme Ass..
PU
2019SHANGHAI PHARMACEUTICALS : Proposed adoption of the share option scheme and the ..
PU
2019SHANGHAI PHARMACEUTICALS : Csrc's approval on issuance of new h shares
PU
2019SHANGHAI PHARMACEUTICALS : Notification Letter and Change Request Form to Regist..
PU
More news
News in other languages on SHANGHAI PHARMACEUTICALS H
01/22ENZYMATICA PUBL : signs agreement with Keyuan Trade for China
2019SHANGHAI PHARMACEUTICALS : Grant of share options under the share option scheme
2019SHANGHAI PHARMACEUTICALS : Results of the extraordinary general meeting, a share..
2019SHANGHAI PHARMACEUTICALS : Notification Letter and Change Request Form to Regist..
2019SHANGHAI PHARMACEUTICALS : Reply slip for holders of h share attending the 2019 ..
More news
Stock Trading Strategies
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD - 01/03
A technical turn-around configuration
BUY
More Stock Trading Analysis
Chart SHANGHAI PHARMACEUTICALS H
Duration : Period :
Shanghai Pharmaceuticals H Technical Analysis Chart | 601607 | CNE000000C82 | MarketScreener
Technical analysis trends SHANGHAI PHARMACEUTICALS H
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Average target price 21,75 CNY
Last Close Price 18,82 CNY
Spread / Highest target 44,5%
Spread / Average Target 15,6%
Spread / Lowest Target -9,30%
EPS Revisions
Managers
NameTitle
Da Wei Liu Deputy Chief Executive Officer
Man Cho President & Executive Director
Jun Zhou Chairman
Bo Shen Chief Financial Officer, Executive Director & VP
Keng Xin Member-Supervisory Board
Sector and Competitors